# Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis

> **NCT06225752** · PHASE3 · RECRUITING · sponsor: **First Affiliated Hospital of Wannan Medical College** · enrollment: 5452 (estimated)

## Conditions studied

- Ischemic Stroke
- TIA

## Interventions

- **DRUG:** Probucol
- **DRUG:** Placebo probucol

## Key facts

- **NCT ID:** NCT06225752
- **Lead sponsor:** First Affiliated Hospital of Wannan Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-15
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-10-31
- **Target enrollment:** 5452 (ESTIMATED)
- **Last updated:** 2024-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06225752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06225752, "Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06225752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*